Fundraising FoxDebiopharm Innovation Fund — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing.
AI & Machine LearningBiotechDigital HealthMedical DevicesSan Francisco, US
Jo Varshney(Founder & Chief Executive Officer)inDr. Vivek Gupta, Ph.D.(Scientific Co-Founder)
Co-investorsAmplify PartnersCerity Partners VenturesColorcon VenturesDeepwater Asset ManagementIntel CapitalLoup Ventures+8 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.